Both in Pharmaceuticals
Gyre Therapeutics vs CorMedix
Over the past year GYRE returned −40.5% and CRMD returned −51.0%; their daily moves had a correlation of 0.36.
GYRE −40.5% CRMD −51.0%Growth of $1, one year, split-adjusted
| Metric | GYRE | CRMD |
|---|---|---|
| Price | $4.56 | $5.70 |
| Market cap | $483.0M | $443.9M |
| Today | −28.94% | −25.46% |
| 1 month | −34.9% | −23.2% |
| 6 months | −41.6% | −26.9% |
| Year to date | −35.5% | −51.0% |
| 1 year | −39.6% | −49.6% |
| Revenue growth (YoY) | −2.1% | +156.5% |
| Gross margin | 92.4% | 75.7% |
| Net margin | −40.1% | 25.5% |
| P/E (TTM) | — | 2.4× |
| Price / sales | 4.0× | 1.0× |
| Net cash | $74.8M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 87.6% | 76.4% |
| Short % of float | 11.5% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).